BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21963744)

  • 1. Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis.
    Matsuda M; Kishida D; Kinoshita T; Hineno A; Shimojima Y; Fukushima K; Ikeda S
    Intern Med; 2011; 50(19):2219-22. PubMed ID: 21963744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukoencephalopathy due to oral methotrexate.
    González-Suárez I; Aguilar-Amat MJ; Trigueros M; Borobia AM; Cruz A; Arpa J
    Cerebellum; 2014 Feb; 13(1):178-83. PubMed ID: 24068485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.
    Raghavendra S; Nair MD; Chemmanam T; Krishnamoorthy T; Radhakrishnan VV; Kuruvilla A
    Eur J Neurol; 2007 Mar; 14(3):309-14. PubMed ID: 17355553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report.
    Yokoo H; Nakazato Y; Harigaya Y; Sasaki N; Igeta Y; Itoh H
    Acta Neuropathol; 2007 Oct; 114(4):425-30. PubMed ID: 17357801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible leukoencephalopathy after oral methotrexate.
    Koppen H; Wessels JA; Ewals JA; Treurniet FE
    J Rheumatol; 2012 Sep; 39(9):1906-7. PubMed ID: 22942312
    [No Abstract]   [Full Text] [Related]  

  • 6. Multifocal leukoencephalopathy in a patient medicated with etanercept and methotrexate for rheumatoid arthritis.
    Yu T; Yang C
    Z Rheumatol; 2024 May; 83(4):297-302. PubMed ID: 37755473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
    Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
    Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review.
    Kougkas N; Dara A; Pagkopoulou E; Dimitriadou A; Papadimitriou E; Avdelidou E; Garyfallos A; Dimitroulas T
    Rheumatol Int; 2022 Oct; 42(10):1849-1854. PubMed ID: 35849191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
    Calvo-Romero JM
    Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of methotrexate on gastrointestinal symptoms in patients with rheumatoid arthritis.
    Asai S; Nagai K; Takahashi N; Watanabe T; Matsumoto T; Asai N; Sobue Y; Ishiguro N; Kojima T
    Int J Rheum Dis; 2019 Feb; 22(2):207-213. PubMed ID: 30168274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature.
    Kaneko Y; Suwa A; Ikeda Y; Hirakata M
    Mod Rheumatol; 2006; 16(1):36-8. PubMed ID: 16622722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].
    Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E
    Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety of methotrexate in the treatment of rheumatoid arthritis.
    Yazici Y
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S65-7. PubMed ID: 21044436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis.
    van der Veen MJ; Dekker JJ; Dinant HJ; van Soesbergen RM; Bijlsma JW
    J Rheumatol; 1995 Sep; 22(9):1766-8. PubMed ID: 8523359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoencephalopathy in a patient taking low dose oral methotrexate therapy for rheumatoid arthritis.
    Worthley SG; McNeil JD
    J Rheumatol; 1995 Feb; 22(2):335-7. PubMed ID: 7738959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
    Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
    Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral methotrexate for the treatment of rheumatoid arthritis.
    Yazici Y; Bata Y
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():46-8. PubMed ID: 24219041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral events related to low-dose methotrexate in rheumatoid arthritis patients.
    Pedrazas CH; Azevedo MN; Torres SR
    Braz Oral Res; 2010; 24(3):368-73. PubMed ID: 20877977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse effects of low-dose methotrexate therapy in rheumatoid arthritis].
    Furuya T; Totokawa S; Nakajima A; Suzuki T; Kashiwazaki S
    Ryumachi; 1996 Oct; 36(5):746-52. PubMed ID: 8969553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate osteopathy, does it exist?
    Maenaut K; Westhovens R; Dequeker J
    J Rheumatol; 1996 Dec; 23(12):2156-9. PubMed ID: 8970056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.